Cardinal Health Brands

Because we work from the acute channel to the home, we’re uniquely positioned to stay ahead, finding product efficiencies that move care forward.



Presource® is the provider of low cost, high quality kitting solutions serving integrated healthcare providers across the continuum of care with innovative products and services that improve their cost effectiveness and their ability to serve patients.

Presource® offers custom and standard kits across all procedural categories including but not limited to, Operating Room, Catheterization Lab, Endo/GI suite, Interventional Radiology, Emergency Room, Labor and Delivery, and Nursing Floors. In addition, Presource® offers a range of minor procedure kits, diagnostic procedure trays, and non-sterile kits.

In addition, Presource® offers a range of Value Added Services and Programs such as:

  • PackManager® : Online access to an interactive pack management tool
  • Signature Savings Program: Savings and component standardization for customer’s pack program(s)
  • Predictable Pricing Model options: A simple and logical approach to procedure pack pricing
  • Procedure Pack Standardization: Data, analytics and tools to help customers standardize the procedure packs across hospitals or IDNs

Laboratory Products

For more than 60 years, Cardinal Health has been servicing the clinical laboratory industry. We provide hospital labs, independent labs, and physician office labs access to more than 80,000 products from 400 manufacturers including 2,000+ Cardinal Health brand products that provide our customers the savings they need.

As a full-line distributor, we service every laboratory discipline – histology, microbiology, general chemistry, hematology and blood bank – through a nationwide distribution network. And the people of the Cardinal Health Laboratory Products team are an important key to serving the industry. One-third of our sales representatives have worked as medical technologists; their average tenure is 14 years.


Cardinal Health acquired Cordis from Johnson & Johnson (JNJ), for approximately $1.9B.  The acquisition closed on Oct 3rd , 2016, providing our Medical Segment a strategic entry into the cardiovascular space.  The official name of Cordis under Cardinal Health is: “Cordis Corporation, a Cardinal Health Company.

Cordis was founded in Miami, Florida, by Dr. William Murphy about 50 years ago, and became well known in the global medical industry, as its name meant innovation, quality and reliability to its end-users.

Currently, Cordis’ revenue is approximately $800M, and its primary products are balloon catheters designed for the diagnosis and treatment of blockages in blood vessels, implantable vascular & Abdominal Aortic Aneurysm stents, and vascular access closure (plugs the access area made in the vessel) devices.

Cordis historically has had its headquarters in Fremont, CA (south of San Francisco) has two manufacturing sites, one in Miami Lakes, FL, and one in Juarez, Mexico.  The Fremont site, is home for the several key functions, like R&D, Engineering, Finance, Quality and Regulatory Affairs, Legal, Global Sourcing, Customer Services, and other groups.  In addition, the Fremont site is outfitted with labs designed for product innovation and testing.

The Miami Lakes plant is highly automated and focused on the conversion of raw materials, mainly resins, into complex compounds used in the manufacturing of large number of extruded tubing, some of which are braided with stainless steel threads.  These tubes are key components of the catheter and stent delivery systems, and others are designed specifically for the manufacture of the angioplasty balloons.

The Juarez site employs over 1,500 employees dedicated to the manufacture of FG.  While the Miami plant supplies 100% of its products as components to its sister plant in Mexico, other RM and component suppliers provide their products directly to Mexico as well.

In addition to self-manufacturing, Cordis acquires FG from other C&V suppliers out of the US, EU and Asia.  The Global Sourcing team, located in both Miami Lakes and Fremont, are responsible managing the supplier relationship and acquisition of RM/Components and FG from their supplier community, globally.

Access Closure Inc., a manufacturer of the Mynx products, which is also a vascular entry-point closure device, is now part of Cordis Corp.

So what does the future hold? Growth.  Key growth pillars are new product introductions, improvements to the existing base products, further acquisitions and expanding customer offerings with Cardinal Health’s broad medical device portfolio at a global scale.

Cordis is now a Cardinal Health company.

Powered to transform.

United to meet the evolving needs of our cardiovascular customers.